Monograph Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$847K Sell
3,334
-1,196
-26% -$279K 0.07% 69
2026
Q1
$1.11M Buy
4,530
+796
+21% +$185K 0.11% 58
2025
Q4
$773K Sell
3,734
-365
-9% -$72.2K 0.08% 71
2025
Q3
$760K Sell
4,099
-23
-0.6% -$3.94K 0.08% 74
2025
Q2
$630K Sell
4,122
-57
-1% -$8.76K 0.08% 68
2025
Q1
$693K Sell
4,179
-279
-6% -$43.7K 0.09% 58
2024
Q4
$645K Buy
4,458
+359
+9% +$55.6K 0.09% 58
2024
Q3
$664K Hold
4,099
0.09% 60
2024
Q2
$599K Sell
4,099
-1,082
-21% -$161K 0.09% 57
2024
Q1
$820K Buy
5,181
+921
+22% +$147K 0.12% 69
2023
Q4
$668K Sell
4,260
-2,358
-36% -$362K 0.12% 45
2023
Q3
$1.03M Buy
6,618
+3,727
+129% +$615K 0.2% 45
2023
Q2
$479K Sell
2,891
-450
-13% -$72.6K 0.1% 50
2023
Q1
$518K Sell
3,341
-626
-16% -$101K 0.12% 45
2022
Q4
$701K Sell
3,967
-621
-14% -$107K 0.19% 41
2022
Q3
$749K Hold
4,588
0.25% 29
2022
Q2
$814K Sell
4,588
-304
-6% -$54.2K 0.24% 31
2022
Q1
$867K Buy
+4,892
New +$832K 0.22% 35

Other funds holding JNJ

Monograph Wealth Advisors's JNJ Position: Q2 2026 in Review

Monograph Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 26% in Q2 2026, selling an estimated $279K and leaving 3,334 shares worth $847K. The position accounts for 0.07% of the portfolio, ranked #69.

Monograph Wealth Advisors first reported a position in JNJ in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.11M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Monograph Wealth Advisors held 3,334 shares of Johnson & Johnson worth $847K as of Q2 2026.
  • Monograph Wealth Advisors sold 1,196 Johnson & Johnson shares in Q2 2026, an estimated $279K.
  • Johnson & Johnson made up 0.07% of Monograph Wealth Advisors's portfolio in Q2 2026, its #69 holding.
  • Monograph Wealth Advisors first reported a position in Johnson & Johnson in Q1 2022 and has held it in 18 quarters since.
  • Monograph Wealth Advisors's Johnson & Johnson position peaked at $1.11M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Monograph Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.